404 related articles for article (PubMed ID: 19262236)
1. Statins and hypertension.
Cífková R; Nilsson PM
J Hypertens; 2009 Mar; 27(3):662-5. PubMed ID: 19262236
[No Abstract] [Full Text] [Related]
2. Are we lowering LDL cholesterol sufficiently?
Barter P; Rye KA
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
[No Abstract] [Full Text] [Related]
3. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
Chodick G; Shalev V
Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
[No Abstract] [Full Text] [Related]
4. [Treatment with statins: lowering of cholesterol or more?].
Rutishauser J
Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
[No Abstract] [Full Text] [Related]
5. [JUPITER study, more reason to give statins as preventive measure - commentary].
Narkiewicz K
Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067
[No Abstract] [Full Text] [Related]
6. JUPITER "moderate CKD" subgroup is not truly "moderate" chronic kidney disease.
Roberts MA; Hare DL
J Am Coll Cardiol; 2010 Aug; 56(6):528; author reply 530. PubMed ID: 20670769
[No Abstract] [Full Text] [Related]
7. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Couzin J
Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
[No Abstract] [Full Text] [Related]
8. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)].
Higashikata T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():628-36. PubMed ID: 15171447
[No Abstract] [Full Text] [Related]
9. New hope for chronic kidney disease patients after the JUPITER trial: myth or reality?
Kassimatis TI; Goldsmith DJ
J Am Coll Cardiol; 2010 Aug; 56(6):529. PubMed ID: 20670770
[No Abstract] [Full Text] [Related]
10. [Statin cuts cardiovascular risk in half].
Einecke D
MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
[No Abstract] [Full Text] [Related]
11. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
12. Time for new indications for statins?
Banach M; Mikhailidis DP; Kjeldsen SE; Rysz J
Med Sci Monit; 2009 Dec; 15(12):MS1-5. PubMed ID: 19946240
[TBL] [Abstract][Full Text] [Related]
13. [How do I choose the best possible statin for my patient?].
Viikari J
Duodecim; 2003; 119(10):954-9. PubMed ID: 12833785
[No Abstract] [Full Text] [Related]
14. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
15. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
[No Abstract] [Full Text] [Related]
16. Statins and hypertension.
Pelat M; Balligand JL
Semin Vasc Med; 2004 Nov; 4(4):367-75. PubMed ID: 15861317
[TBL] [Abstract][Full Text] [Related]
17. Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
Perlmutter D; Golomb B; Sinatra S; Campbell AW
Altern Ther Health Med; 2013; 19 Suppl 1():14-25. PubMed ID: 23981463
[No Abstract] [Full Text] [Related]
18. [Treatment of dyslipoproteinemia in chronic renal failure].
Krane V; Wanner C
MMW Fortschr Med; 2006 Apr; 148(14):34-7. PubMed ID: 16669278
[TBL] [Abstract][Full Text] [Related]
19. [Hypertension and hyperlipidemia].
Hansen HS; Larsen ML
Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
[TBL] [Abstract][Full Text] [Related]
20. Are statins effective in high-risk primary prevention?
Dentali F; Guasti L
Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
